0001127602-12-014940.txt : 20120430 0001127602-12-014940.hdr.sgml : 20120430 20120430165833 ACCESSION NUMBER: 0001127602-12-014940 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120427 FILED AS OF DATE: 20120430 DATE AS OF CHANGE: 20120430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morris Charles Q CENTRAL INDEX KEY: 0001489966 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29815 FILM NUMBER: 12795920 MAIL ADDRESS: STREET 1: C/O ALLOS THERAPEUTICS, INC. STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001097264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 541655029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 BUSINESS PHONE: 3034266262 MAIL ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-04-27 0001097264 ALLOS THERAPEUTICS INC ALTH 0001489966 Morris Charles Q 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020 1 Chief Medical Officer Common Stock 2012-04-27 4 S 0 7970 1.8101 D 665323 D These shares are being sold pursuant to a 10b5-1 plan for Charles Q. Morris in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on April 26, 2012. /s/ David C. Clark, Attorney-in-Fact for Charles Q. Morris 2012-04-30